Zymeworks Inc. shared a post on Linkedin:
”We’re proud to share a recent publication in Cancer Discovery (AACR Journals): ‘The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development’ by Raffaele Colombo, Jamie Rich, Paolo Tarantino, Patricia LoRusso, and Elisabeth (Liesbeth) de Vries.
This comprehensive review traces the evolution of antibody-drug conjugates (ADCs), highlighting key milestones and insights from four decades of research. Inspired by discussions at last year’s AACR-NCI-EORTC triple meeting, it offers valuable perspective on ADC development. We’re excited to contribute to the scientific community’s understanding of ADCs and their therapeutic potential.”
The Journey of Antibody–Drug Conjugates: Lessons Learned from 40 Years of Development
Authors: Raffaele Colombo, Paolo Tarantino, Jamie R. Rich, Patricia M. LoRusso, Elisabeth G.E. de Vries.
